Cargando…
Δcps1 vaccine protects dogs against experimentally induced coccidioidomycosis
Coccidioidomycosis is a significant health problem of dogs and humans in endemic regions, especially California and Arizona in the U.S. Both species would greatly benefit from a vaccine to prevent this disease. A live avirulent vaccine candidate, Δcps1, was tested for tolerability and efficacy to pr...
Autores principales: | Shubitz, Lisa F., Robb, Edward J., Powell, Daniel A., Bowen, Richard A., Bosco-Lauth, Angela, Hartwig, Airn, Porter, Stephanie M., Trinh, Hien, Moale, Hilary, Bielefeldt-Ohmann, Helle, Hoskinson, James, Orbach, Marc J., Frelinger, Jeffrey A., Galgiani, John N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9186468/ https://www.ncbi.nlm.nih.gov/pubmed/34696935 http://dx.doi.org/10.1016/j.vaccine.2021.10.029 |
Ejemplares similares
-
1732. A Canine Target Species Challenge Model to Evaluate Efficacy of a Coccidioidomycosis Vaccine
por: Shubitz, Lisa F, et al.
Publicado: (2019) -
Vaccine Protection of Mice With Primary Immunodeficiencies Against Disseminated Coccidioidomycosis
por: Powell, Daniel A., et al.
Publicado: (2022) -
Susceptibility of Wild Canids to SARS-CoV-2
por: Porter, Stephanie M., et al.
Publicado: (2022) -
Reactivation of Coccidioidomycosis in a Mouse Model of Asymptomatic Controlled Disease
por: Shubitz, Lisa F., et al.
Publicado: (2022) -
Susceptibility of livestock to SARS-CoV-2 infection
por: Bosco-Lauth, Angela M., et al.
Publicado: (2021)